common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

This is a Phase I, randomized, placebo and active-controlled, double blind, single and multiple ascending dose study in healthy adults to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of KP-1199

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - KP-1199

Single dose and Multiple ascending doses of KP-1199 oral capsules

Drug - Placebo oral capsule

Single dose and Multiple dose identical to active treatment but without KP-1199.

Drug - Oxycodone oral capsule

10 mg Oxycodone Capsules

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Randomized, Placebo- and Active-Controlled, Double-Blind, Single and Multiple Ascending Dose Study in Healthy Adults to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KP-1199

common.study.values.clinical-trial-id

NCT03880487

participant.views.study.view.id

b4xwkb